Characterizing pharmacist impact in maintenance therapy for adolescent and young adults with acute lymphoblastic leukemia treated with CALGB 10403 protocol

Cami Andreini, Brian Lam, Taylor Dennison, Jessica Auten, Kaitlyn M Buhlinger, Stephen M Clark, Benyam Muluneh, Allison B Carroll, Laura Klos, Wenqing Zhu, Hailey Hirata, Bianka Patel

Journal of Oncology Pharmacy Practice

Published online on March 03, 2026

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionCancer and Leukemia Group B (CALGB) 10403 is a pediatric-inspired treatment protocol for adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL) patients. During Course V maintenance, patients receive mercaptopurine (6MP) and oral ...